(S (NP-SBJ (NP A/DT novel/JJ SP-1/NN site/NN) (PP in/IN (NP the/DT human/JJ interleukin-1/NN beta/NN promoter/NN))) (VP confers/VBZ (NP (NP preferential/JJ transcriptional/JJ activity/NN) (PP in/IN (NP keratinocytes/NNS)))) ./.)
(S (S (NP-SBJ *-38/-NONE-) (VP To/TO (VP investigate/VB (NP (NP the/DT mechanisms/NNS) (PP of/IN (NP (NP transcriptional/JJ activation/NN) (PP of/IN (NP (NP interleukin-1beta/NN) (PRN -LRB-/-LRB- (NP IL-1beta/NN) -RRB-/-RRB-))) (PP in/IN (NP non-monocytic/JJ cells/NNS)))))))) ,/, (NP-SBJ-38 we/PRP) (VP-COOD (VP constructed/VBD (NP (NP a/DT series/NN) (PP of/IN (NP (NP reporter/NN plasmids/NNS) (PP with/IN (NP (NP the/DT bacterial/JJ chloramphenicol/NN acetyltransferase/NN gene/NN) (VP linked/VBN (NP */-NONE-) (PP to/TO (NP (NP various/JJ parts/NNS) (PP of/IN (NP the/DT human/JJ IL-1beta/NN promoter/NN))))))))))) and/CC (VP performed/VBD (NP transient/JJ transfection/NN experiments/NNS))) ./.)
(S (NP-SBJ We/PRP) (VP identified/VBD (NP (NP a/DT promoter/NN segment/NN) (SBAR (WHNP-39 that/WDT) (S (NP-SBJ *T*-39/-NONE-) (VP activates/VBZ (NP transcription/NN) (ADVP most/RBS efficiently/RB) (PP in/IN (NP keratinocytes/NNS))))))) ./.)
(S (NP-SBJ (NP (NP Electrophoretic/JJ mobility/NN shift/NN assays/NNS) (PRN -LRB-/-LRB- (NP EMSA/NN) -RRB-/-RRB-)) (PP with/IN (NP (NP a/DT (ADJP 43-mer/NN) oligonucleotide/NN) (VP derived/VBN (NP */-NONE-) (PP from/IN (NP the/DT (ADJP functionally/RB identified/VBN) cis-acting/JJ element/NN)))))) (VP revealed/VBD (NP specific/JJ complexes/NNS)) ./.)
(S (PP-COOD (PP By/IN (NP-LGS (NP competition/NN analysis/NN) (PP with/IN (NP transcription/NN factor/NN consensus/NN sequence/NN oligonucleotides/NNS)))) and/CC (PP by/IN (NP-LGS immunosupershift/NN))) ,/, (NP-SBJ-COOD-40 (NP transcription/NN factor/NN SP-1/NN) or/CC (NP a/DT (ADJP closely/RB related/JJ) protein/NN)) (VP was/VBD (VP shown/VBN (S (NP-SBJ *-40/-NONE-) (VP to/TO (VP bind/VBP (PP to/TO (NP this/DT regulatory/JJ element/NN))))))) ./.)
(S (NP-SBJ (NP The/DT closest/JJS match/NN) (PP to/TO (NP the/DT known/VBN SP-1/NN consensus/NN sequence/NN)) (PP within/IN (NP the/DT respective/JJ region/NN))) (VP is/VBZ (NP-PRD a/DT TCCCCTCCCCT/NN motif/NN)) ./.)
(S (NP-SBJ (NP Mutation/NN) (PP of/IN (NP this/DT motif/NN))) (VP-COOD (VP (ADVP-COOD (ADVP almost/RB completely/RB) ,/, and/CC (ADVP specifically/RB) ,/,) abolished/VBD (NP (NP the/DT binding/NN) (PP of/IN (NP two/CD low-mobility/JJ complexes/NNS)))) and/CC (VP led/VBD (PP to/TO (NP (NP a/DT 95/CD %/NN decrease/NN) (PP of/IN (NP (NP constitutive/JJ transcriptional/JJ activation/NN) (PP of/IN (NP (NP a/DT reporter/NN construct/NN IL-1beta/NN) (PRN -LRB-/-LRB- (NP -170\/+108/CD) -RRB-/-RRB-))))))))) ./.)
(S (ADVP Likewise/RB) ,/, (NP-SBJ (NP activation/NN) (PP of/IN (NP this/DT reporter/NN construct/NN)) (PP by/IN (NP tumor/NN necrosis/NN factor-alpha/NN))) (VP depended/VBD (PP on/IN (NP the/DT SP-1/NN site/NN))) ./.)
(S (NP-SBJ These/DT observations/NNS) (VP suggest/VBP (SBAR that/IN (S (NP-SBJ (NP a/DT so-far-unrecognized/JJ SP-1/NN site/NN) (PP in/IN (NP the/DT human/JJ IL-1beta/NN promoter/NN))) (VP may/MD (VP participate/VB (PP in/IN (NP (NP the/DT transcriptional/JJ regulation/NN) (PP of/IN (NP this/DT gene/NN)) (PP in/IN (NP keratinocytes/NNS))))))))) ./.)
